GEN - Genetic Engineering and Biotechnology News

The Quest for Large-Scale DNA

As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

GEMMABio Awarded ARPA-H Funding to Pursue Innovative Base-editing Strategy for Rare Liver Diseases

Gemma Biotherapeutics ("GEMMABio"), a clinical-stage, global, genetic medicines company, today announced that it has been awarded funding by the Advanced Research Projects Agency for Health (ARPA-H).